Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis

[1]  Priya Singh,et al.  Sildenafil citrate and uteroplacental perfusion in fetal growth restriction , 2018, International Journal of Reproduction, Contraception, Obstetrics and Gynecology.

[2]  A. Singh,et al.  Effect of l-Arginine on Nitric Oxide Levels in Intrauterine Growth Restriction and its Correlation with Fetal Outcome , 2014, Indian Journal of Clinical Biochemistry.

[3]  Juelin Deng,et al.  Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: A systematic review , 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[4]  V. Berghella,et al.  Intrauterine Growth Restriction (IUGR): Etiology and Diagnosis , 2013, Current Obstetrics and Gynecology Reports.

[5]  M. V. Dastjerdi,et al.  Sildenafil citrate and uteroplacental perfusion in fetal growth restriction , 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[6]  J. Strauss,et al.  Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medicalfood on pre-eclampsia in high risk population : Randomised controlled trial , 2019 .

[7]  Cai Hua,et al.  Effect of L-arginine on the expression of Bcl-2 and Bax in the placenta of fetal growth restriction , 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[8]  Francesc Figueras,et al.  Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. , 2011, American Journal of Obstetrics and Gynecology.

[9]  A. Gruslin,et al.  Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction , 2011, BJOG : an international journal of obstetrics and gynaecology.

[10]  G. Mires,et al.  A Randomised, Double-Blinded, Placebo-Controlled Study of the Phosphodiesterase Type 5 Inhibitor Sildenafil for the Treatment of Preeclampsia , 2009, Hypertension in pregnancy.

[11]  B. Branger,et al.  L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial. , 2009, Clinical nutrition.

[12]  Sung Woo Kim,et al.  Arginine metabolism and nutrition in growth, health and disease , 2009, Amino Acids.

[13]  F. Bloomfield,et al.  Treatment of intrauterine growth restriction with maternal growth hormone supplementation in sheep. , 2008, American journal of obstetrics and gynecology.

[14]  oanna,et al.  The effect of L-arginine treatment on the neonatal outcome from pregnancies complicated by intrauterine growth restriction and gestational hypertension , 2008 .

[15]  H. .,et al.  The effect of L-arginine on fetal outcome in IUGR fetuses , 2008 .

[16]  L. Ignarro,et al.  The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. , 2007, Pharmacology & therapeutics.

[17]  Guoyao Wu,et al.  Pharmacokinetics and safety of arginine supplementation in animals. , 2007, The Journal of nutrition.

[18]  G. Grimble.  Adverse gastrointestinal effects of arginine and related amino acids. , 2007, The Journal of nutrition.

[19]  Xin Xiao,et al.  [Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension]. , 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[20]  R. Olszanecki,et al.  Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. , 2006, Basic & clinical pharmacology & toxicology.

[21]  R. Sokol,et al.  Sildenafil Citrate and Fetal Outcome in Pregnant Rats , 2006, Fetal Diagnosis and Therapy.

[22]  M. Druzin,et al.  Effect of l-Arginine Therapy on the Glomerular Injury of Preeclampsia: A Randomized Controlled Trial , 2006, Obstetrics and gynecology.

[23]  A. Denjean,et al.  Effect of Nω-Nitro-l-Arginine Methyl Ester–Induced Intrauterine Growth Restriction on Postnatal Lung Growth in Rats , 2005, Pediatric Research.

[24]  C. Moinard,et al.  Almost all about citrulline in mammals , 2005, Amino Acids.

[25]  P. Baker,et al.  Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  X. M. Xiao,et al.  l‐Arginine treatment for asymmetric fetal growth restriction , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[27]  A. Germain,et al.  Letter to the Editor Evidence Supporting a Beneficial Role for Long-Term l-Arginine Supplementation in High-Risk Pregnancies , 2004 .

[28]  J. Suzin,et al.  Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine) , 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[29]  A. Germain,et al.  Management of Eisenmenger Syndrome in Pregnancy With Sildenafil and l-arginine , 2004, Obstetrics and gynecology.

[30]  Guoyao Wu,et al.  Dietary arginine supplementation enhances the growth of milk-fed young pigs. , 2004, The Journal of nutrition.

[31]  T. Henriksen,et al.  Dietary supplementation with l‐arginine or placebo in women with pre‐eclampsia , 2004, Acta obstetricia et gynecologica Scandinavica.

[32]  Guoyao Wu,et al.  Developmental Changes in Polyamine Levels and Synthesis in the Ovine Conceptus1 , 2003, Biology of reproduction.

[33]  P. Casanello,et al.  Intrauterine Growth Retardation Is Associated With Reduced Activity and Expression of the Cationic Amino Acid Transport Systems y+/hCAT-1 and y+/hCAT-2B and Lower Activity of Nitric Oxide Synthase in Human Umbilical Vein Endothelial Cells , 2002, Circulation research.

[34]  W. Paulus,et al.  Benefit of vaginal sildenafil citrate in assisted reproduction therapy. , 2002, Fertility and sterility.

[35]  Guoyao Wu,et al.  Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. , 2000 .

[36]  F. Facchinetti,et al.  Increased L‐Citrulline/ L‐Arginine Plasma Ratio in Severe Preeclampsia , 2000, Obstetrics and gynecology.

[37]  G. Sher,et al.  Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. , 2000, Human reproduction.

[38]  F. Facchinetti,et al.  L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. , 1999, Journal of the Society for Gynecologic Investigation.

[39]  I. Greer,et al.  Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. , 1997, Human reproduction.

[40]  F. Facchinetti,et al.  Effects of L‐arginine on utero‐placental circulation in growth‐retarded fetuses , 1996, Acta obstetricia et gynecologica Scandinavica.

[41]  G. Dekker,et al.  Nitric oxide, the endothelium, pregnancy and pre‐eclampsia , 1996, British journal of obstetrics and gynaecology.